Fig. 1From: Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trialCumulative incidence of distant recurrence/death due to breast cancer (DM), or cumulative incidence of relapse, stratified by CanAssist Breast (CAB) at ten years for the total cohort or subgroups. A DM for the total cohort. B Cumulative incidence of relapse for the total cohort. C Lymph node-positive subgroup. D Lymph node stage N0-1 subgroupBack to article page